{
  "policy_id": "IP0660",
  "policy_number": "IP0660",
  "policy_title": "Infliximab Intravenous Products Prior Authorization Policy",
  "payer_name": "cigna",
  "medication_name": "infliximab",
  "medication_brand_names": [
    "Avsola",
    "Inflectra",
    "Remicade",
    "Renflexis"
  ],
  "medication_generic_names": [
    "infliximab",
    "infliximab-axxq",
    "infliximab-dyyb",
    "infliximab-abda"
  ],
  "medication_codes": [
    {
      "system": "HCPCS",
      "code": "J1745",
      "display": "Injection, infliximab, excludes biosimilar, 10 mg"
    },
    {
      "system": "HCPCS",
      "code": "Q5103",
      "display": "Injection, infliximab-dyyb, biosimilar, (Inflectra), 10 mg"
    },
    {
      "system": "HCPCS",
      "code": "Q5104",
      "display": "Injection, infliximab-abda, biosimilar, (Renflexis), 10 mg"
    },
    {
      "system": "HCPCS",
      "code": "Q5121",
      "display": "Injection, infliximab-axxq, biosimilar, (Avsola), 10 mg"
    }
  ],
  "effective_date": "2026-01-01",
  "last_revision_date": "2026-01-01",
  "atomic_criteria": {
    "AGE_GE_18": {
      "criterion_id": "AGE_GE_18",
      "criterion_type": "age",
      "name": "Age >= 18 years",
      "description": "Patient is 18 years of age or older",
      "policy_text": "Patient is >= 18 years of age",
      "clinical_codes": [],
      "comparison_operator": "gte",
      "threshold_value": 18,
      "threshold_value_upper": null,
      "threshold_unit": "years",
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "demographics",
      "criterion_category": "demographics",
      "source_section": "FDA-Approved Indications",
      "source_page": 5,
      "source_text_excerpt": "Patient is >= 18 years of age",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "demographics.age",
      "evaluation_strategy": "numeric_compare",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "AGE_GE_6": {
      "criterion_id": "AGE_GE_6",
      "criterion_type": "age",
      "name": "Age >= 6 years",
      "description": "Patient is 6 years of age or older",
      "policy_text": "Patient is >= 6 years of age",
      "clinical_codes": [],
      "comparison_operator": "gte",
      "threshold_value": 6,
      "threshold_value_upper": null,
      "threshold_unit": "years",
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "demographics",
      "criterion_category": "demographics",
      "source_section": "FDA-Approved Indications",
      "source_page": 6,
      "source_text_excerpt": "Patient is >= 6 years of age",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "demographics.age",
      "evaluation_strategy": "numeric_compare",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "PRESCRIBER_RHEUM": {
      "criterion_id": "PRESCRIBER_RHEUM",
      "criterion_type": "prescriber_specialty",
      "name": "Prescribed by Rheumatologist",
      "description": "The medication is prescribed by or in consultation with a rheumatologist",
      "policy_text": "The medication is prescribed by or in consultation with a rheumatologist",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [
        "rheumatologist"
      ],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "prescriber",
      "criterion_category": "prescriber",
      "source_section": "FDA-Approved Indications",
      "source_page": 5,
      "source_text_excerpt": "The medication is prescribed by or in consultation with a rheumatologist",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "prescriber.specialty",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "PRESCRIBER_GI": {
      "criterion_id": "PRESCRIBER_GI",
      "criterion_type": "prescriber_specialty",
      "name": "Prescribed by Gastroenterologist",
      "description": "The medication is prescribed by or in consultation with a gastroenterologist",
      "policy_text": "The medication is prescribed by or in consultation with a gastroenterologist",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [
        "gastroenterologist"
      ],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "prescriber",
      "criterion_category": "prescriber",
      "source_section": "FDA-Approved Indications",
      "source_page": 6,
      "source_text_excerpt": "The medication is prescribed by or in consultation with a gastroenterologist",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "prescriber.specialty",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "PRESCRIBER_DERM": {
      "criterion_id": "PRESCRIBER_DERM",
      "criterion_type": "prescriber_specialty",
      "name": "Prescribed by Dermatologist",
      "description": "The medication is prescribed by or in consultation with a dermatologist",
      "policy_text": "The medication is prescribed by or in consultation with a dermatologist",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [
        "dermatologist"
      ],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "prescriber",
      "criterion_category": "prescriber",
      "source_section": "FDA-Approved Indications",
      "source_page": 7,
      "source_text_excerpt": "The medication is prescribed by or in consultation with a dermatologist",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "prescriber.specialty",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "PRESCRIBER_RHEUM_DERM": {
      "criterion_id": "PRESCRIBER_RHEUM_DERM",
      "criterion_type": "prescriber_specialty",
      "name": "Prescribed by Rheumatologist or Dermatologist",
      "description": "The medication is prescribed by or in consultation with a rheumatologist or a dermatologist",
      "policy_text": "The medication is prescribed by or in consultation with a rheumatologist or a dermatologist",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [
        "rheumatologist",
        "dermatologist"
      ],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "prescriber",
      "criterion_category": "prescriber",
      "source_section": "FDA-Approved Indications",
      "source_page": 8,
      "source_text_excerpt": "The medication is if prescribed by or in consultation with a rheumatologist or a dermatologist",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "prescriber.specialty",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "PRESCRIBER_OPHTH": {
      "criterion_id": "PRESCRIBER_OPHTH",
      "criterion_type": "prescriber_specialty",
      "name": "Prescribed by Ophthalmologist",
      "description": "The medication is prescribed by or in consultation with an ophthalmologist",
      "policy_text": "The medication is prescribed by or in consultation with an ophthalmologist",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [
        "ophthalmologist"
      ],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "prescriber",
      "criterion_category": "prescriber",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 15,
      "source_text_excerpt": "The medication is prescribed by or in consultation with an ophthalmologist",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "prescriber.specialty",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "STEP_CD_STEROIDS": {
      "criterion_id": "STEP_CD_STEROIDS",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Corticosteroids (Crohn's)",
      "description": "Patient has tried or is currently taking corticosteroids, or corticosteroids are contraindicated",
      "policy_text": "Patient has tried or is currently taking corticosteroids, or corticosteroids are contraindicated in this patient",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "prednisone",
        "methylprednisolone"
      ],
      "drug_classes": [
        "corticosteroids"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 6,
      "source_text_excerpt": "Patient has tried or is currently taking corticosteroids, or corticosteroids are contraindicated in this patient",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "8640",
          "display": "prednisone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisone"
        },
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_CD_CONVENTIONAL": {
      "criterion_id": "STEP_CD_CONVENTIONAL",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Conventional Systemic Therapy (Crohn's)",
      "description": "Patient has tried one other conventional systemic therapy for Crohn's disease (e.g., azathioprine, 6-mercaptopurine, methotrexate)",
      "policy_text": "Patient has tried one other conventional systemic therapy for Crohn's disease... Examples... include azathioprine, 6-mercaptopurine, or methotrexate.",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "azathioprine",
        "6-mercaptopurine",
        "methotrexate"
      ],
      "drug_classes": [
        "conventional systemic therapy"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 6,
      "source_text_excerpt": "Patient has tried one other conventional systemic therapy for Crohn's disease",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_name",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "1256",
          "display": "azathioprine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "azathioprine"
        },
        {
          "system": "RxNorm",
          "code": "6691",
          "display": "mercaptopurine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "6-mercaptopurine"
        },
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        }
      ],
      "minimum_duration_days": null
    },
    "EXCEPTION_BIOLOGIC_BYPASS": {
      "criterion_id": "EXCEPTION_BIOLOGIC_BYPASS",
      "criterion_type": "prior_treatment_tried",
      "name": "Exception: Prior Biologic Trial",
      "description": "Patient has already tried at least one biologic other than the requested medication. A biosimilar of the requested biologic does not count.",
      "policy_text": "An exception to the requirement... can be made if the patient has already tried at least one biologic other than the requested medication. A biosimilar of the requested biologic does not count.",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [
        "biologic"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 6,
      "source_text_excerpt": "An exception to the requirement... can be made if the patient has already tried at least one biologic other than the requested medication.",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "CLINICAL_CD_FISTULAS": {
      "criterion_id": "CLINICAL_CD_FISTULAS",
      "criterion_type": "diagnosis_confirmed",
      "name": "Presence of Fistulas",
      "description": "Patient has enterocutaneous (perianal or abdominal) or rectovaginal fistulas",
      "policy_text": "Patient has enterocutaneous (perianal or abdominal) or rectovaginal fistulas",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": false,
      "category": "diagnosis",
      "criterion_category": "diagnosis",
      "source_section": "FDA-Approved Indications",
      "source_page": 6,
      "source_text_excerpt": "Patient has enterocutaneous (perianal or abdominal) or rectovaginal fistulas",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "diagnoses[].condition",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "K60.3",
          "display": "Anal fistula",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "perianal... fistulas"
        },
        {
          "system": "ICD-10-CM",
          "code": "K63.2",
          "display": "Fistula of intestine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "enterocutaneous... fistulas"
        },
        {
          "system": "ICD-10-CM",
          "code": "N82.3",
          "display": "Fistula of vagina to large intestine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "rectovaginal fistulas"
        }
      ],
      "minimum_duration_days": null
    },
    "CLINICAL_CD_RESECTION": {
      "criterion_id": "CLINICAL_CD_RESECTION",
      "criterion_type": "custom",
      "name": "Ileocolonic Resection",
      "description": "Patient had ileocolonic resection (to reduce the chance of Crohn's disease recurrence)",
      "policy_text": "Patient had ileocolonic resection (to reduce the chance of Crohn's disease recurrence)",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 6,
      "source_text_excerpt": "Patient had ileocolonic resection",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "procedures[].name",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "CPT",
          "code": "44160",
          "display": "Colectomy, partial, with removal of terminal ileum with ileocolostomy",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "ileocolonic resection"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_PSO_SYSTEMIC": {
      "criterion_id": "STEP_PSO_SYSTEMIC",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Traditional Systemic Agent (Psoriasis)",
      "description": "Patient has tried at least one traditional systemic agent for psoriasis for at least 3 months, unless intolerant",
      "policy_text": "Patient has tried at least one traditional systemic agent for psoriasis for at least 3 months, unless intolerant... Examples include methotrexate, cyclosporine, or acitretin",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "methotrexate",
        "cyclosporine",
        "acitretin"
      ],
      "drug_classes": [
        "traditional systemic agent"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 7,
      "source_text_excerpt": "Patient has tried at least one traditional systemic agent for psoriasis for at least 3 months",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_name",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        },
        {
          "system": "RxNorm",
          "code": "3008",
          "display": "cyclosporine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "cyclosporine"
        },
        {
          "system": "RxNorm",
          "code": "28889",
          "display": "acitretin",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "acitretin"
        }
      ],
      "minimum_duration_days": 90
    },
    "STEP_PSO_PUVA": {
      "criterion_id": "STEP_PSO_PUVA",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of PUVA",
      "description": "A 3-month trial of psoralen plus ultraviolet A light (PUVA)",
      "policy_text": "A 3-month trial of psoralen plus ultraviolet A light (PUVA) also counts.",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 7,
      "source_text_excerpt": "A 3-month trial of psoralen plus ultraviolet A light (PUVA) also counts.",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "procedures[].name",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "CPT",
          "code": "96912",
          "display": "Photochemotherapy; psoralens and ultraviolet A (PUVA)",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "psoralen plus ultraviolet A light (PUVA)"
        }
      ],
      "minimum_duration_days": 90
    },
    "EXCEPTION_PSO_PRIOR_BIOLOGIC_OR_ORAL": {
      "criterion_id": "EXCEPTION_PSO_PRIOR_BIOLOGIC_OR_ORAL",
      "criterion_type": "prior_treatment_tried",
      "name": "Exception: Prior Biologic, Otezla, or Sotyktu",
      "description": "Patient already had a 3-month trial or previous intolerance to at least one biologic, Otezla/Otezla XR, or Sotyktu",
      "policy_text": "An exception... can be made if the patient already had a 3-month trial or previous intolerance to at least one biologic... Otezla/Otezla XR... or Sotyktu",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "apremilast",
        "deucravacitinib"
      ],
      "drug_classes": [
        "biologic"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 7,
      "source_text_excerpt": "An exception... can be made if the patient already had a 3-month trial or previous intolerance to at least one biologic... Otezla/Otezla XR... or Sotyktu",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_name",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "1535922",
          "display": "apremilast",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Otezla"
        },
        {
          "system": "RxNorm",
          "code": "2601666",
          "display": "deucravacitinib",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Sotyktu"
        }
      ],
      "minimum_duration_days": null
    },
    "CONTRAINDICATION_MTX": {
      "criterion_id": "CONTRAINDICATION_MTX",
      "criterion_type": "prior_treatment_contraindicated",
      "name": "Contraindication to Methotrexate",
      "description": "According to the prescriber, the patient has a contraindication to methotrexate",
      "policy_text": "According to the prescriber, the patient has a contraindication to methotrexate",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "methotrexate"
      ],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 7,
      "source_text_excerpt": "According to the prescriber, the patient has a contraindication to methotrexate",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].contraindications",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_RA_DMARD": {
      "criterion_id": "STEP_RA_DMARD",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Conventional Synthetic DMARD (RA)",
      "description": "Patient has tried ONE conventional synthetic DMARD for at least 3 months",
      "policy_text": "Patient has tried ONE conventional synthetic disease-modifying antirheumatic drug (DMARD) for at least 3 months",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "methotrexate",
        "leflunomide",
        "hydroxychloroquine",
        "sulfasalazine"
      ],
      "drug_classes": [
        "conventional synthetic DMARD"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 8,
      "source_text_excerpt": "Patient has tried ONE conventional synthetic disease-modifying antirheumatic drug (DMARD) for at least 3 months",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        },
        {
          "system": "RxNorm",
          "code": "215485",
          "display": "leflunomide",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "leflunomide"
        },
        {
          "system": "RxNorm",
          "code": "5521",
          "display": "hydroxychloroquine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "hydroxychloroquine"
        },
        {
          "system": "RxNorm",
          "code": "10237",
          "display": "sulfasalazine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "sulfasalazine"
        }
      ],
      "minimum_duration_days": 90
    },
    "STEP_BEHCET_CONVENTIONAL": {
      "criterion_id": "STEP_BEHCET_CONVENTIONAL",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Conventional Therapy (Behcet's)",
      "description": "Patient has tried at least ONE conventional therapy (e.g., corticosteroids, immunosuppressants)",
      "policy_text": "Patient has tried at least ONE conventional therapy... Examples include systemic corticosteroids... immunosuppressants",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "methylprednisolone",
        "azathioprine",
        "methotrexate",
        "mycophenolate mofetil",
        "cyclosporine",
        "tacrolimus",
        "chlorambucil",
        "cyclophosphamide",
        "interferon alfa"
      ],
      "drug_classes": [
        "corticosteroids",
        "immunosuppressants"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 10,
      "source_text_excerpt": "Patient has tried at least ONE conventional therapy",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        },
        {
          "system": "RxNorm",
          "code": "1256",
          "display": "azathioprine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "azathioprine"
        },
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        },
        {
          "system": "RxNorm",
          "code": "7052",
          "display": "mycophenolate mofetil",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "mycophenolate mofetil"
        },
        {
          "system": "RxNorm",
          "code": "3008",
          "display": "cyclosporine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "cyclosporine"
        },
        {
          "system": "RxNorm",
          "code": "42316",
          "display": "tacrolimus",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "tacrolimus"
        },
        {
          "system": "RxNorm",
          "code": "2356",
          "display": "chlorambucil",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "chlorambucil"
        },
        {
          "system": "RxNorm",
          "code": "2915",
          "display": "cyclophosphamide",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "cyclophosphamide"
        },
        {
          "system": "RxNorm",
          "code": "253182",
          "display": "interferon alfa",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "interferon alfa"
        }
      ],
      "minimum_duration_days": null
    },
    "CLINICAL_BEHCET_OPHTHALMIC": {
      "criterion_id": "CLINICAL_BEHCET_OPHTHALMIC",
      "criterion_type": "diagnosis_confirmed",
      "name": "Ophthalmic Manifestations of Behcet's",
      "description": "Patient has ophthalmic manifestations of Behcet's disease",
      "policy_text": "Patient has ophthalmic manifestations of Behcet's disease",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": false,
      "category": "diagnosis",
      "criterion_category": "diagnosis",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 10,
      "source_text_excerpt": "Patient has ophthalmic manifestations of Behcet's disease",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "diagnoses[].condition",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "M35.2",
          "display": "Behcet's disease",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Behcet's disease"
        }
      ],
      "minimum_duration_days": null
    },
    "DIAG_ACUTE_GVHD": {
      "criterion_id": "DIAG_ACUTE_GVHD",
      "criterion_type": "diagnosis_confirmed",
      "name": "Acute GVHD",
      "description": "Patient has acute graft-versus-host disease",
      "policy_text": "Patient has acute graft-versus-host disease",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "diagnosis",
      "criterion_category": "diagnosis",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 10,
      "source_text_excerpt": "Patient has acute graft-versus-host disease",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "diagnoses[].condition",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "D89.811",
          "display": "Acute graft-versus-host disease",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "acute graft-versus-host disease"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_GVHD_SYSTEMIC": {
      "criterion_id": "STEP_GVHD_SYSTEMIC",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Systemic Medication (GVHD)",
      "description": "Patient has tried at least one systemic medication for graft-versus-host disease",
      "policy_text": "Patient has tried at least one systemic medication for graft-versus-host disease",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "methylprednisolone",
        "antithymocyte globulin",
        "cyclosporine",
        "tacrolimus",
        "mycophenolate mofetil",
        "ruxolitinib",
        "basiliximab",
        "etanercept",
        "sirolimus",
        "pentostatin",
        "tocilizumab",
        "vedolizumab"
      ],
      "drug_classes": [
        "systemic medication"
      ],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 10,
      "source_text_excerpt": "Patient has tried at least one systemic medication for graft-versus-host disease",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        },
        {
          "system": "RxNorm",
          "code": "3008",
          "display": "cyclosporine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "cyclosporine"
        },
        {
          "system": "RxNorm",
          "code": "42316",
          "display": "tacrolimus",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "tacrolimus"
        },
        {
          "system": "RxNorm",
          "code": "7052",
          "display": "mycophenolate mofetil",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "mycophenolate mofetil"
        },
        {
          "system": "RxNorm",
          "code": "1156598",
          "display": "ruxolitinib",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "ruxolitinib"
        },
        {
          "system": "RxNorm",
          "code": "85206",
          "display": "basiliximab",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "basiliximab"
        },
        {
          "system": "RxNorm",
          "code": "150639",
          "display": "etanercept",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "etanercept"
        },
        {
          "system": "RxNorm",
          "code": "36567",
          "display": "sirolimus",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "sirolimus"
        },
        {
          "system": "RxNorm",
          "code": "32665",
          "display": "pentostatin",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "pentostatin"
        },
        {
          "system": "RxNorm",
          "code": "354892",
          "display": "tocilizumab",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "tocilizumab"
        },
        {
          "system": "RxNorm",
          "code": "1536328",
          "display": "vedolizumab",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "vedolizumab"
        },
        {
          "system": "RxNorm",
          "code": "1094219",
          "display": "antithymocyte globulin",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "antithymocyte globulin"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_HS_THERAPY": {
      "criterion_id": "STEP_HS_THERAPY",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of One Other Therapy (HS)",
      "description": "Patient has tried one other therapy (e.g., intralesional/oral steroids, systemic antibiotics, isotretinoin)",
      "policy_text": "Patient has tried one other therapy... Examples include intralesional or oral corticosteroids... systemic antibiotics... and isotretinoin.",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "triamcinolone",
        "prednisone",
        "clindamycin",
        "dicloxacillin",
        "erythromycin",
        "isotretinoin"
      ],
      "drug_classes": [
        "corticosteroids",
        "systemic antibiotics"
      ],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 11,
      "source_text_excerpt": "Patient has tried one other therapy",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "10759",
          "display": "triamcinolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "triamcinolone"
        },
        {
          "system": "RxNorm",
          "code": "8640",
          "display": "prednisone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisone"
        },
        {
          "system": "RxNorm",
          "code": "2582",
          "display": "clindamycin",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "clindamycin"
        },
        {
          "system": "RxNorm",
          "code": "3322",
          "display": "dicloxacillin",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "dicloxacillin"
        },
        {
          "system": "RxNorm",
          "code": "4053",
          "display": "erythromycin",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "erythromycin"
        },
        {
          "system": "RxNorm",
          "code": "6064",
          "display": "isotretinoin",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "isotretinoin"
        }
      ],
      "minimum_duration_days": null
    },
    "CLINICAL_IMMUNO_TOX": {
      "criterion_id": "CLINICAL_IMMUNO_TOX",
      "criterion_type": "diagnosis_confirmed",
      "name": "Immunotherapy-Related Toxicity",
      "description": "Patient developed an immunotherapy-related toxicity other than hepatitis while receiving a checkpoint inhibitor",
      "policy_text": "According to the prescriber, patient developed an immunotherapy-related toxicity other than hepatitis... while receiving a checkpoint inhibitor",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "pembrolizumab",
        "nivolumab",
        "ipilimumab",
        "atezolizumab",
        "avelumab",
        "durvalumab"
      ],
      "drug_classes": [
        "checkpoint inhibitor"
      ],
      "evidence_types": [],
      "is_required": true,
      "category": "diagnosis",
      "criterion_category": "diagnosis",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 12,
      "source_text_excerpt": "patient developed an immunotherapy-related toxicity other than hepatitis",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "diagnoses[].condition",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "T45.1X5",
          "display": "Adverse effect of antineoplastic and immunosuppressive drugs",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "immunotherapy-related toxicity"
        },
        {
          "system": "RxNorm",
          "code": "1547545",
          "display": "pembrolizumab",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "pembrolizumab"
        },
        {
          "system": "RxNorm",
          "code": "1597876",
          "display": "nivolumab",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "nivolumab"
        },
        {
          "system": "RxNorm",
          "code": "1094219",
          "display": "ipilimumab",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "ipilimumab"
        },
        {
          "system": "RxNorm",
          "code": "1792776",
          "display": "atezolizumab",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "atezolizumab"
        },
        {
          "system": "RxNorm",
          "code": "1919503",
          "display": "avelumab",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "avelumab"
        },
        {
          "system": "RxNorm",
          "code": "1923282",
          "display": "durvalumab",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "durvalumab"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_IMMUNO_TOX_STEROID": {
      "criterion_id": "STEP_IMMUNO_TOX_STEROID",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Systemic Corticosteroid (Immuno Tox)",
      "description": "Patient has tried one systemic corticosteroid",
      "policy_text": "Patient has tried one systemic corticosteroid",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "methylprednisolone",
        "prednisone"
      ],
      "drug_classes": [
        "systemic corticosteroid"
      ],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 12,
      "source_text_excerpt": "Patient has tried one systemic corticosteroid",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        },
        {
          "system": "RxNorm",
          "code": "8640",
          "display": "prednisone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisone"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_INDETERMINATE_COLITIS": {
      "criterion_id": "STEP_INDETERMINATE_COLITIS",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Steroid, Mesalamine, and Immunomodulator",
      "description": "Patient has tried one systemic corticosteroid AND mesalamine AND either azathioprine or 6-mercaptopurine",
      "policy_text": "Patient has tried one systemic corticosteroid; AND Patient has tried mesalamine; AND Patient has tried either azathioprine or 6-mercaptopurine",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "prednisone",
        "methylprednisolone",
        "mesalamine",
        "azathioprine",
        "6-mercaptopurine"
      ],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 12,
      "source_text_excerpt": "Patient has tried one systemic corticosteroid; AND Patient has tried mesalamine; AND Patient has tried either azathioprine or 6-mercaptopurine",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_name",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "8640",
          "display": "prednisone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisone"
        },
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        },
        {
          "system": "RxNorm",
          "code": "6918",
          "display": "mesalamine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "mesalamine"
        },
        {
          "system": "RxNorm",
          "code": "1256",
          "display": "azathioprine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "azathioprine"
        },
        {
          "system": "RxNorm",
          "code": "6691",
          "display": "mercaptopurine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "6-mercaptopurine"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_JIA_SYSTEMIC": {
      "criterion_id": "STEP_JIA_SYSTEMIC",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Systemic Medication (JIA)",
      "description": "Patient has tried one other systemic medication for this condition",
      "policy_text": "Patient has tried one other systemic medication for this condition... Examples... include methotrexate, sulfasalazine, or leflunomide, a nonsteroidal anti-inflammatory drug (NSAID)",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "methotrexate",
        "sulfasalazine",
        "leflunomide",
        "ibuprofen",
        "naproxen"
      ],
      "drug_classes": [
        "NSAID",
        "DMARD"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 13,
      "source_text_excerpt": "Patient has tried one other systemic medication for this condition",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        },
        {
          "system": "RxNorm",
          "code": "10237",
          "display": "sulfasalazine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "sulfasalazine"
        },
        {
          "system": "RxNorm",
          "code": "215485",
          "display": "leflunomide",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "leflunomide"
        },
        {
          "system": "RxNorm",
          "code": "5640",
          "display": "ibuprofen",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "ibuprofen"
        },
        {
          "system": "RxNorm",
          "code": "7258",
          "display": "naproxen",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "naproxen"
        }
      ],
      "minimum_duration_days": null
    },
    "CLINICAL_JIA_AGGRESSIVE": {
      "criterion_id": "CLINICAL_JIA_AGGRESSIVE",
      "criterion_type": "diagnosis_severity",
      "name": "Aggressive JIA",
      "description": "Patient has aggressive disease, as determined by the prescriber",
      "policy_text": "Patient has aggressive disease, as determined by the prescriber",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": false,
      "category": "diagnosis",
      "criterion_category": "diagnosis",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 13,
      "source_text_excerpt": "Patient has aggressive disease, as determined by the prescriber",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "diagnoses[].severity",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "STEP_PYODERMA_STEROID": {
      "criterion_id": "STEP_PYODERMA_STEROID",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Systemic Corticosteroid (Pyoderma)",
      "description": "Patient has tried one systemic corticosteroid",
      "policy_text": "Patient has tried one systemic corticosteroid",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "prednisone",
        "methylprednisolone"
      ],
      "drug_classes": [
        "systemic corticosteroid"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 14,
      "source_text_excerpt": "Patient has tried one systemic corticosteroid",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "8640",
          "display": "prednisone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisone"
        },
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_PYODERMA_IMMUNO": {
      "criterion_id": "STEP_PYODERMA_IMMUNO",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Immunosuppressant (Pyoderma)",
      "description": "Patient has tried one other immunosuppressant for at least 2 months or was intolerant",
      "policy_text": "Patient has tried one other immunosuppressant for at least 2 months or was intolerant to one of these medications",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "mycophenolate mofetil",
        "cyclosporine"
      ],
      "drug_classes": [
        "immunosuppressant"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 14,
      "source_text_excerpt": "Patient has tried one other immunosuppressant for at least 2 months",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "7052",
          "display": "mycophenolate mofetil",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "mycophenolate mofetil"
        },
        {
          "system": "RxNorm",
          "code": "3008",
          "display": "cyclosporine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "cyclosporine"
        }
      ],
      "minimum_duration_days": 60
    },
    "STEP_SARCOIDOSIS": {
      "criterion_id": "STEP_SARCOIDOSIS",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Steroid AND Immunosuppressant (Sarcoidosis)",
      "description": "Patient has tried at least one corticosteroid AND at least one immunosuppressive medication",
      "policy_text": "Patient has tried at least one corticosteroid; AND Patient has tried at least one immunosuppressive medication",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "prednisone",
        "methylprednisolone",
        "methotrexate",
        "azathioprine",
        "leflunomide",
        "mycophenolate mofetil",
        "hydroxychloroquine",
        "chloroquine"
      ],
      "drug_classes": [
        "corticosteroid",
        "immunosuppressive"
      ],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 15,
      "source_text_excerpt": "Patient has tried at least one corticosteroid; AND Patient has tried at least one immunosuppressive medication",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "8640",
          "display": "prednisone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisone"
        },
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        },
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        },
        {
          "system": "RxNorm",
          "code": "1256",
          "display": "azathioprine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "azathioprine"
        },
        {
          "system": "RxNorm",
          "code": "215485",
          "display": "leflunomide",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "leflunomide"
        },
        {
          "system": "RxNorm",
          "code": "7052",
          "display": "mycophenolate mofetil",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "mycophenolate mofetil"
        },
        {
          "system": "RxNorm",
          "code": "5521",
          "display": "hydroxychloroquine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "hydroxychloroquine"
        },
        {
          "system": "RxNorm",
          "code": "2393",
          "display": "chloroquine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "chloroquine"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_SCLERITIS": {
      "criterion_id": "STEP_SCLERITIS",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of One Other Therapy (Scleritis)",
      "description": "Patient has tried one other therapy for this condition (e.g., NSAIDs, corticosteroids, methotrexate, cyclosporine)",
      "policy_text": "Patient has tried one other therapy for this condition",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "indomethacin",
        "prednisone",
        "prednisolone",
        "methylprednisolone",
        "methotrexate",
        "cyclosporine"
      ],
      "drug_classes": [
        "NSAID",
        "corticosteroid",
        "immunosuppressant"
      ],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 15,
      "source_text_excerpt": "Patient has tried one other therapy for this condition",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "5775",
          "display": "indomethacin",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "indomethacin"
        },
        {
          "system": "RxNorm",
          "code": "8640",
          "display": "prednisone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisone"
        },
        {
          "system": "RxNorm",
          "code": "8638",
          "display": "prednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisolone"
        },
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        },
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        },
        {
          "system": "RxNorm",
          "code": "3008",
          "display": "cyclosporine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "cyclosporine"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_SPA_PERIPHERAL": {
      "criterion_id": "STEP_SPA_PERIPHERAL",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Conventional DMARD (Peripheral SpA)",
      "description": "Patient has arthritis primarily in the peripheral joints AND has tried at least ONE conventional synthetic DMARD",
      "policy_text": "Patient has arthritis primarily in the knees, ankles, elbows, wrists, hands, and/or feet AND has tried at least ONE conventional synthetic disease-modifying antirheumatic drug (DMARD)",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "methotrexate",
        "leflunomide",
        "sulfasalazine"
      ],
      "drug_classes": [
        "conventional synthetic DMARD"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 16,
      "source_text_excerpt": "Patient has arthritis primarily in the knees... AND has tried at least ONE conventional synthetic disease-modifying antirheumatic drug",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        },
        {
          "system": "RxNorm",
          "code": "215485",
          "display": "leflunomide",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "leflunomide"
        },
        {
          "system": "RxNorm",
          "code": "10237",
          "display": "sulfasalazine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "sulfasalazine"
        }
      ],
      "minimum_duration_days": null
    },
    "CLINICAL_SPA_AXIAL": {
      "criterion_id": "CLINICAL_SPA_AXIAL",
      "criterion_type": "clinical_marker_present",
      "name": "Axial SpA with Objective Inflammation",
      "description": "Patient has axial spondyloarthritis with objective signs of inflammation (elevated CRP or sacroiliitis on MRI)",
      "policy_text": "Patient has axial spondyloarthritis with objective signs of inflammation, defined as at least one of the following: (1) C-reactive protein elevated... OR (2) Sacroiliitis reported on magnetic resonance imaging",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": false,
      "category": "diagnosis",
      "criterion_category": "diagnosis",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 16,
      "source_text_excerpt": "Patient has axial spondyloarthritis with objective signs of inflammation",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "diagnoses[].condition",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "LOINC",
          "code": "1988-5",
          "display": "C reactive protein [Mass/volume] in Serum or Plasma",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "C-reactive protein elevated"
        },
        {
          "system": "CPT",
          "code": "73720",
          "display": "Magnetic resonance (eg, proton) imaging, lower extremity joint(s), without contrast material(s)",
          "source": "inferred",
          "consensus_status": "rejected",
          "parent_code": null,
          "concept_text": "Sacroiliitis reported on magnetic resonance imaging"
        },
        {
          "system": "CPT",
          "code": "72198",
          "display": "Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "Sacroiliitis reported on magnetic resonance imaging"
        }
      ],
      "minimum_duration_days": null
    },
    "STEP_STILLS_THERAPY": {
      "criterion_id": "STEP_STILLS_THERAPY",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Steroid AND DMARD (Still's)",
      "description": "Patient has tried one corticosteroid AND one conventional synthetic DMARD (for at least 2 months or intolerant)",
      "policy_text": "Patient has tried one corticosteroid; AND Patient has tried one conventional synthetic disease-modifying antirheumatic drug (DMARD) given for at least 2 months or was intolerant",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "prednisone",
        "methylprednisolone",
        "methotrexate"
      ],
      "drug_classes": [
        "corticosteroid",
        "conventional synthetic DMARD"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 17,
      "source_text_excerpt": "Patient has tried one corticosteroid; AND Patient has tried one conventional synthetic disease-modifying antirheumatic drug (DMARD) given for at least 2 months",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "8640",
          "display": "prednisone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisone"
        },
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        },
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        }
      ],
      "minimum_duration_days": 60
    },
    "STEP_UVEITIS_THERAPY": {
      "criterion_id": "STEP_UVEITIS_THERAPY",
      "criterion_type": "prior_treatment_tried",
      "name": "Trial of Therapy (Uveitis)",
      "description": "Patient has tried one of the following therapies: periocular, intraocular, or systemic corticosteroids, or immunosuppressives",
      "policy_text": "Patient has tried one of the following therapies: periocular, intraocular, or systemic corticosteroids, or immunosuppressives",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [
        "prednisolone",
        "triamcinolone",
        "betamethasone",
        "methylprednisolone",
        "prednisone",
        "methotrexate",
        "mycophenolate mofetil",
        "cyclosporine"
      ],
      "drug_classes": [
        "corticosteroids",
        "immunosuppressives"
      ],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 18,
      "source_text_excerpt": "Patient has tried one of the following therapies: periocular, intraocular, or systemic corticosteroids, or immunosuppressives",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].drug_class",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "RxNorm",
          "code": "8638",
          "display": "prednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisolone"
        },
        {
          "system": "RxNorm",
          "code": "10759",
          "display": "triamcinolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "triamcinolone"
        },
        {
          "system": "RxNorm",
          "code": "1514",
          "display": "betamethasone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "betamethasone"
        },
        {
          "system": "RxNorm",
          "code": "6902",
          "display": "methylprednisolone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methylprednisolone"
        },
        {
          "system": "RxNorm",
          "code": "8640",
          "display": "prednisone",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "prednisone"
        },
        {
          "system": "RxNorm",
          "code": "6851",
          "display": "methotrexate",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "methotrexate"
        },
        {
          "system": "RxNorm",
          "code": "7052",
          "display": "mycophenolate mofetil",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "mycophenolate mofetil"
        },
        {
          "system": "RxNorm",
          "code": "3008",
          "display": "cyclosporine",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "cyclosporine"
        }
      ],
      "minimum_duration_days": null
    },
    "CONTINUATION_ESTABLISHED_6MO": {
      "criterion_id": "CONTINUATION_ESTABLISHED_6MO",
      "criterion_type": "prior_treatment_duration",
      "name": "Established on Therapy (6 Months)",
      "description": "Patient has been established on therapy for at least 6 months",
      "policy_text": "Patient has been established on therapy for at least 6 months",
      "clinical_codes": [],
      "comparison_operator": "gte",
      "threshold_value": 6,
      "threshold_value_upper": null,
      "threshold_unit": "months",
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 5,
      "source_text_excerpt": "Patient has been established on therapy for at least 6 months",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].duration_months",
      "evaluation_strategy": "numeric_compare",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": 180
    },
    "CONTINUATION_ESTABLISHED_3MO": {
      "criterion_id": "CONTINUATION_ESTABLISHED_3MO",
      "criterion_type": "prior_treatment_duration",
      "name": "Established on Therapy (3 Months)",
      "description": "Patient has been established on therapy for at least 3 months",
      "policy_text": "Patient has been established on therapy for at least 3 months",
      "clinical_codes": [],
      "comparison_operator": "gte",
      "threshold_value": 3,
      "threshold_value_upper": null,
      "threshold_unit": "months",
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 7,
      "source_text_excerpt": "Patient has been established on therapy for at least 3 months",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].duration_months",
      "evaluation_strategy": "numeric_compare",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": 90
    },
    "CONTINUATION_ESTABLISHED_1MO": {
      "criterion_id": "CONTINUATION_ESTABLISHED_1MO",
      "criterion_type": "prior_treatment_duration",
      "name": "Established on Therapy (1 Month)",
      "description": "Patient has been established on therapy for at least 1 month",
      "policy_text": "Patient has been established on an infliximab product for at least 1 month",
      "clinical_codes": [],
      "comparison_operator": "gte",
      "threshold_value": 1,
      "threshold_value_upper": null,
      "threshold_unit": "months",
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 11,
      "source_text_excerpt": "Patient has been established on an infliximab product for at least 1 month",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].duration_months",
      "evaluation_strategy": "numeric_compare",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": 30
    },
    "CONTINUATION_ESTABLISHED_4MO": {
      "criterion_id": "CONTINUATION_ESTABLISHED_4MO",
      "criterion_type": "prior_treatment_duration",
      "name": "Established on Therapy (4 Months)",
      "description": "Patient has been established on therapy for at least 4 months",
      "policy_text": "Patient has been established on therapy for at least 4 months",
      "clinical_codes": [],
      "comparison_operator": "gte",
      "threshold_value": 4,
      "threshold_value_upper": null,
      "threshold_unit": "months",
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "Other Uses with Supportive Evidence",
      "source_page": 14,
      "source_text_excerpt": "Patient has been established on therapy for at least 4 months",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].duration_months",
      "evaluation_strategy": "numeric_compare",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": 120
    },
    "RESPONSE_OBJECTIVE_AS": {
      "criterion_id": "RESPONSE_OBJECTIVE_AS",
      "criterion_type": "response_assessment",
      "name": "Objective Response (AS)",
      "description": "Patient experienced a beneficial clinical response assessed by at least one objective measure",
      "policy_text": "When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline... Examples... include ASDAS, ASQoL, BASDAI, BASFI, BAS-G, BASMI, DFI, HAQ-S, CRP, ESR",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [
        "ASDAS",
        "ASQoL",
        "BASDAI",
        "BASFI",
        "BAS-G",
        "BASMI",
        "DFI",
        "HAQ-S",
        "CRP",
        "ESR"
      ],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 6,
      "source_text_excerpt": "When assessed by at least one objective measure, patient experienced a beneficial clinical response",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].response_measures",
      "evaluation_strategy": "list_contains",
      "codes_validated": false,
      "enriched_codes": [
        {
          "system": "LOINC",
          "code": "31747-9",
          "display": "Bath Ankylosing Spondylitis Disease Activity Index [BASDAI]",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "BASDAI"
        },
        {
          "system": "LOINC",
          "code": "1988-5",
          "display": "C reactive protein [Mass/volume] in Serum or Plasma",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "CRP"
        },
        {
          "system": "LOINC",
          "code": "30341-2",
          "display": "Erythrocyte sedimentation rate [Length/time] in Blood",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "ESR"
        }
      ],
      "minimum_duration_days": null
    },
    "RESPONSE_SUBJECTIVE_AS": {
      "criterion_id": "RESPONSE_SUBJECTIVE_AS",
      "criterion_type": "response_assessment",
      "name": "Subjective Response (AS)",
      "description": "Patient experienced an improvement in at least one symptom",
      "policy_text": "Patient experienced an improvement in at least one symptom, such as decreased pain or stiffness, or improvement in function or activities of daily living",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": false,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": "FDA-Approved Indications",
      "source_page": 6,
      "source_text_excerpt": "Patient experienced an improvement in at least one symptom",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "treatment_history[].response_measures",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "PREFERRED_PRODUCT_REQUIRED": {
      "criterion_id": "PREFERRED_PRODUCT_REQUIRED",
      "criterion_type": "custom",
      "name": "Preferred Product Requirement",
      "description": "Preferred infliximab products must be used. Preferred products are biosimilars: Inflectra (infliximab-dyyb), Avsola (infliximab-axxq), Renflexis (infliximab-abda). Remicade (reference infliximab) is non-preferred and requires trial of a preferred product first. Refer to PSM005 for the complete preferred product list.",
      "policy_text": "This product also requires the use of preferred products before approval of a requested non-preferred infliximab intravenous product.",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [
        "Inflectra",
        "Avsola",
        "Renflexis"
      ],
      "drug_names": [
        "infliximab-dyyb",
        "infliximab-axxq",
        "infliximab-abda"
      ],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "formulary",
      "criterion_category": "formulary",
      "source_section": "Policy Statement",
      "source_page": 5,
      "source_text_excerpt": "This product also requires the use of preferred products before approval of a requested non-preferred infliximab intravenous product.",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "formulary.preferred_products",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "GRP_RA_CONTINUATION": {
      "criterion_id": "GRP_RA_CONTINUATION",
      "criterion_type": "custom",
      "name": "Rheumatoid Arthritis Continuation",
      "description": "Missing continuation criteria group for Rheumatoid Arthritis",
      "policy_text": "Patient is Currently Receiving an Infliximab Product. Approve for 1 year if the patient meets BOTH of the following (i and ii): i. Patient has been established on therapy for at least 6 months; AND ii. Patient meets at least ONE of the following (a or b): a) Patient experienced a beneficial clinical response when assessed by at least one objective measure; OR b) Patient experienced an improvement in at least one symptom",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": null,
      "source_page": null,
      "source_text_excerpt": "",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": null,
      "evaluation_strategy": null,
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "GRP_UC_CONTINUATION": {
      "criterion_id": "GRP_UC_CONTINUATION",
      "criterion_type": "custom",
      "name": "Ulcerative Colitis Continuation",
      "description": "Missing continuation criteria group for Ulcerative Colitis",
      "policy_text": "Patient is Currently Receiving an Infliximab Product. Approve for 1 year if the patient meets BOTH of the following (i and ii): i. Patient has been established on therapy for at least 6 months; AND ii. Patient meets at least ONE of the following (a or b): a) When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline; OR b) Compared with baseline, patient experienced an improvement in at least one symptom",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": null,
      "source_page": null,
      "source_text_excerpt": "",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": null,
      "evaluation_strategy": null,
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "GRP_BEHCET_CONTINUATION": {
      "criterion_id": "GRP_BEHCET_CONTINUATION",
      "criterion_type": "custom",
      "name": "Behcet's Disease Continuation",
      "description": "Missing continuation criteria group for Behcet's Disease",
      "policy_text": "Patient is Currently Receiving an Infliximab Product. Approve for 1 year if the patient meets ALL of the following (i, ii, and iii): i. Patient has been established on therapy for at least 3 months; AND ii. When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline; AND iii. Compared with baseline, patient experienced an improvement in at least one symptom",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "treatment_history",
      "criterion_category": "treatment_history",
      "source_section": null,
      "source_page": null,
      "source_text_excerpt": "",
      "extraction_confidence": "low",
      "validation_status": null,
      "patient_data_path": null,
      "evaluation_strategy": null,
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "PRESCRIBER_NEURO": {
      "criterion_id": "PRESCRIBER_NEURO",
      "criterion_type": "prescriber_specialty",
      "name": "Prescribed by Neurologist",
      "description": "The medication is prescribed by or in consultation with a neurologist",
      "policy_text": "The medication is prescribed by or in consultation with a rheumatologist, dermatologist, ophthalmologist, gastroenterologist, or neurologist",
      "clinical_codes": [],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [],
      "is_required": true,
      "category": "prescriber",
      "criterion_category": "prescriber",
      "source_section": null,
      "source_page": null,
      "source_text_excerpt": "",
      "extraction_confidence": "medium",
      "validation_status": null,
      "patient_data_path": null,
      "evaluation_strategy": null,
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "SAFETY_TB_NEGATIVE": {
      "criterion_id": "SAFETY_TB_NEGATIVE",
      "criterion_type": "safety_screening_negative",
      "name": "Tuberculosis Screening",
      "description": "Patient must have a negative TB test (QuantiFERON-TB Gold or tuberculin skin test) prior to initiating infliximab therapy",
      "policy_text": "Patients must be evaluated for tuberculosis (TB) risk factors and tested for latent TB infection prior to initiating therapy",
      "clinical_codes": [
        {
          "system": "LOINC",
          "code": "71774-4",
          "display": "QuantiFERON-TB Gold Plus"
        },
        {
          "system": "CPT",
          "code": "86480",
          "display": "Tuberculosis test, cell mediated immunity antigen response"
        }
      ],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [
        "negative"
      ],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [
        "lab_result",
        "screening_report"
      ],
      "is_required": true,
      "category": "safety_screening",
      "criterion_category": "safety",
      "source_section": "Warnings and Precautions",
      "source_page": null,
      "source_text_excerpt": "Patients must be evaluated for tuberculosis risk factors and tested for latent TB infection prior to initiating therapy",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "lab_results.tb_screening",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    },
    "SAFETY_HEPATITIS_SCREENING": {
      "criterion_id": "SAFETY_HEPATITIS_SCREENING",
      "criterion_type": "safety_screening_completed",
      "name": "Hepatitis B and C Screening",
      "description": "Patient must have hepatitis B (HBsAg, anti-HBc, anti-HBs) and hepatitis C (HCV antibody) screening completed prior to initiating infliximab therapy",
      "policy_text": "Patients should be tested for hepatitis B virus infection before initiating treatment. Hepatitis C screening is also recommended prior to biologic therapy",
      "clinical_codes": [
        {
          "system": "LOINC",
          "code": "5196-1",
          "display": "Hepatitis B surface antigen (HBsAg)"
        },
        {
          "system": "LOINC",
          "code": "16933-4",
          "display": "Hepatitis B core antibody (anti-HBc)"
        },
        {
          "system": "LOINC",
          "code": "22322-2",
          "display": "Hepatitis C antibody"
        }
      ],
      "comparison_operator": null,
      "threshold_value": null,
      "threshold_value_upper": null,
      "threshold_unit": null,
      "allowed_values": [],
      "drug_names": [],
      "drug_classes": [],
      "evidence_types": [
        "lab_result",
        "screening_report"
      ],
      "is_required": true,
      "category": "safety_screening",
      "criterion_category": "safety",
      "source_section": "Warnings and Precautions",
      "source_page": null,
      "source_text_excerpt": "Patients should be tested for hepatitis B virus infection before initiating treatment",
      "extraction_confidence": "high",
      "validation_status": null,
      "patient_data_path": "lab_results.hepatitis_screening",
      "evaluation_strategy": "boolean_check",
      "codes_validated": false,
      "enriched_codes": [],
      "minimum_duration_days": null
    }
  },
  "criterion_groups": {
    "GRP_AS_INITIAL": {
      "group_id": "GRP_AS_INITIAL",
      "name": "Ankylosing Spondylitis Initial",
      "description": "Initial criteria for Ankylosing Spondylitis",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "PRESCRIBER_RHEUM",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_AS_CONTINUATION": {
      "group_id": "GRP_AS_CONTINUATION",
      "name": "Ankylosing Spondylitis Continuation",
      "description": "Continuation criteria for Ankylosing Spondylitis",
      "operator": "AND",
      "criteria": [
        "CONTINUATION_ESTABLISHED_6MO"
      ],
      "subgroups": [
        "SUBGRP_AS_RESPONSE"
      ],
      "negated": false
    },
    "SUBGRP_AS_RESPONSE": {
      "group_id": "SUBGRP_AS_RESPONSE",
      "name": "AS Response",
      "description": "Objective or Subjective Response for AS",
      "operator": "OR",
      "criteria": [
        "RESPONSE_OBJECTIVE_AS",
        "RESPONSE_SUBJECTIVE_AS"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_CD_INITIAL": {
      "group_id": "GRP_CD_INITIAL",
      "name": "Crohn's Disease Initial",
      "description": "Initial criteria for Crohn's Disease",
      "operator": "AND",
      "criteria": [
        "AGE_GE_6",
        "PRESCRIBER_GI",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [
        "SUBGRP_CD_STEP",
        "SUBGRP_CD_SAFETY"
      ],
      "negated": false
    },
    "SUBGRP_CD_STEP": {
      "group_id": "SUBGRP_CD_STEP",
      "name": "CD Step Therapy",
      "description": "One of: Steroids, Conventional, Fistulas, Resection, or Biologic Exception",
      "operator": "OR",
      "criteria": [
        "STEP_CD_STEROIDS",
        "STEP_CD_CONVENTIONAL",
        "CLINICAL_CD_FISTULAS",
        "CLINICAL_CD_RESECTION",
        "EXCEPTION_BIOLOGIC_BYPASS"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_CD_CONTINUATION": {
      "group_id": "GRP_CD_CONTINUATION",
      "name": "Crohn's Disease Continuation",
      "description": "Continuation criteria for Crohn's Disease",
      "operator": "AND",
      "criteria": [
        "CONTINUATION_ESTABLISHED_6MO"
      ],
      "subgroups": [
        "SUBGRP_CD_RESPONSE"
      ],
      "negated": false
    },
    "SUBGRP_CD_RESPONSE": {
      "group_id": "SUBGRP_CD_RESPONSE",
      "name": "CD Response",
      "description": "Objective or Subjective Response for CD",
      "operator": "OR",
      "criteria": [
        "RESPONSE_OBJECTIVE_CD",
        "RESPONSE_SUBJECTIVE_CD"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_PSO_INITIAL": {
      "group_id": "GRP_PSO_INITIAL",
      "name": "Plaque Psoriasis Initial",
      "description": "Initial criteria for Plaque Psoriasis",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "PRESCRIBER_DERM",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [
        "SUBGRP_PSO_STEP"
      ],
      "negated": false
    },
    "SUBGRP_PSO_STEP": {
      "group_id": "SUBGRP_PSO_STEP",
      "name": "PsO Step Therapy",
      "description": "Systemic/PUVA trial OR Exception (Biologic/Otezla/Sotyktu) OR MTX Contraindication",
      "operator": "OR",
      "criteria": [
        "STEP_PSO_SYSTEMIC",
        "STEP_PSO_PUVA",
        "EXCEPTION_PSO_PRIOR_BIOLOGIC_OR_ORAL",
        "CONTRAINDICATION_MTX"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_PSO_CONTINUATION": {
      "group_id": "GRP_PSO_CONTINUATION",
      "name": "Plaque Psoriasis Continuation",
      "description": "Continuation criteria for Plaque Psoriasis",
      "operator": "AND",
      "criteria": [
        "CONTINUATION_ESTABLISHED_3MO"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_RA_INITIAL": {
      "group_id": "GRP_RA_INITIAL",
      "name": "Rheumatoid Arthritis Initial",
      "description": "Initial criteria for Rheumatoid Arthritis",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "PRESCRIBER_RHEUM",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [
        "SUBGRP_RA_STEP"
      ],
      "negated": false
    },
    "SUBGRP_RA_STEP": {
      "group_id": "SUBGRP_RA_STEP",
      "name": "RA Step Therapy",
      "description": "DMARD trial OR Biologic Exception",
      "operator": "OR",
      "criteria": [
        "STEP_RA_DMARD",
        "EXCEPTION_BIOLOGIC_BYPASS"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_UC_INITIAL": {
      "group_id": "GRP_UC_INITIAL",
      "name": "Ulcerative Colitis Initial",
      "description": "Initial criteria for Ulcerative Colitis",
      "operator": "AND",
      "criteria": [
        "AGE_GE_6",
        "PRESCRIBER_GI",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_BEHCET_INITIAL": {
      "group_id": "GRP_BEHCET_INITIAL",
      "name": "Behcet's Disease Initial",
      "description": "Initial criteria for Behcet's Disease",
      "operator": "AND",
      "criteria": [
        "AGE_GE_6",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [
        "SUBGRP_BEHCET_STEP",
        "SUBGRP_BEHCET_PRESCRIBER"
      ],
      "negated": false
    },
    "SUBGRP_BEHCET_STEP": {
      "group_id": "SUBGRP_BEHCET_STEP",
      "name": "Behcet's Step Therapy",
      "description": "Conventional therapy OR Biologic Exception OR Ophthalmic Manifestations",
      "operator": "OR",
      "criteria": [
        "STEP_BEHCET_CONVENTIONAL",
        "EXCEPTION_BIOLOGIC_BYPASS",
        "CLINICAL_BEHCET_OPHTHALMIC"
      ],
      "subgroups": [],
      "negated": false
    },
    "SUBGRP_BEHCET_PRESCRIBER": {
      "group_id": "SUBGRP_BEHCET_PRESCRIBER",
      "name": "Behcet's Prescriber",
      "description": "Rheum, Derm, Ophth, GI, or Neuro",
      "operator": "OR",
      "criteria": [
        "PRESCRIBER_RHEUM",
        "PRESCRIBER_DERM",
        "PRESCRIBER_OPHTH",
        "PRESCRIBER_GI"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_GVHD_INITIAL": {
      "group_id": "GRP_GVHD_INITIAL",
      "name": "GVHD Initial",
      "description": "Initial criteria for GVHD",
      "operator": "AND",
      "criteria": [
        "AGE_GE_6",
        "DIAG_ACUTE_GVHD",
        "STEP_GVHD_SYSTEMIC",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_HS_INITIAL": {
      "group_id": "GRP_HS_INITIAL",
      "name": "Hidradenitis Suppurativa Initial",
      "description": "Initial criteria for HS",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "STEP_HS_THERAPY",
        "PRESCRIBER_DERM",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_IMMUNO_TOX_INITIAL": {
      "group_id": "GRP_IMMUNO_TOX_INITIAL",
      "name": "Immunotherapy Toxicity Initial",
      "description": "Initial criteria for Immunotherapy Toxicity",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "CLINICAL_IMMUNO_TOX",
        "STEP_IMMUNO_TOX_STEROID",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_INDETERMINATE_COLITIS_INITIAL": {
      "group_id": "GRP_INDETERMINATE_COLITIS_INITIAL",
      "name": "Indeterminate Colitis Initial",
      "description": "Initial criteria for Indeterminate Colitis",
      "operator": "AND",
      "criteria": [
        "AGE_GE_6",
        "STEP_INDETERMINATE_COLITIS",
        "PRESCRIBER_GI",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_JIA_INITIAL": {
      "group_id": "GRP_JIA_INITIAL",
      "name": "JIA Initial",
      "description": "Initial criteria for JIA",
      "operator": "AND",
      "criteria": [
        "AGE_GE_6",
        "PRESCRIBER_RHEUM",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [
        "SUBGRP_JIA_STEP"
      ],
      "negated": false
    },
    "SUBGRP_JIA_STEP": {
      "group_id": "SUBGRP_JIA_STEP",
      "name": "JIA Step Therapy",
      "description": "Systemic therapy OR Biologic Exception OR Aggressive Disease",
      "operator": "OR",
      "criteria": [
        "STEP_JIA_SYSTEMIC",
        "EXCEPTION_BIOLOGIC_BYPASS",
        "CLINICAL_JIA_AGGRESSIVE"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_PYODERMA_INITIAL": {
      "group_id": "GRP_PYODERMA_INITIAL",
      "name": "Pyoderma Gangrenosum Initial",
      "description": "Initial criteria for Pyoderma Gangrenosum",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "PRESCRIBER_DERM",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [
        "SUBGRP_PYODERMA_STEP"
      ],
      "negated": false
    },
    "SUBGRP_PYODERMA_STEP": {
      "group_id": "SUBGRP_PYODERMA_STEP",
      "name": "Pyoderma Step Therapy",
      "description": "Steroid OR Immunosuppressant",
      "operator": "OR",
      "criteria": [
        "STEP_PYODERMA_STEROID",
        "STEP_PYODERMA_IMMUNO"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_SARCOIDOSIS_INITIAL": {
      "group_id": "GRP_SARCOIDOSIS_INITIAL",
      "name": "Sarcoidosis Initial",
      "description": "Initial criteria for Sarcoidosis",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "STEP_SARCOIDOSIS",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_SCLERITIS_INITIAL": {
      "group_id": "GRP_SCLERITIS_INITIAL",
      "name": "Scleritis Initial",
      "description": "Initial criteria for Scleritis",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "STEP_SCLERITIS",
        "PRESCRIBER_OPHTH",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_SPA_INITIAL": {
      "group_id": "GRP_SPA_INITIAL",
      "name": "Spondyloarthritis Initial",
      "description": "Initial criteria for Other SpA",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "PRESCRIBER_RHEUM",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [
        "SUBGRP_SPA_STEP"
      ],
      "negated": false
    },
    "SUBGRP_SPA_STEP": {
      "group_id": "SUBGRP_SPA_STEP",
      "name": "SpA Step Therapy",
      "description": "Peripheral + DMARD OR Axial + Inflammation",
      "operator": "OR",
      "criteria": [
        "STEP_SPA_PERIPHERAL",
        "CLINICAL_SPA_AXIAL"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_STILLS_INITIAL": {
      "group_id": "GRP_STILLS_INITIAL",
      "name": "Still's Disease Initial",
      "description": "Initial criteria for Still's Disease",
      "operator": "AND",
      "criteria": [
        "AGE_GE_18",
        "PRESCRIBER_RHEUM",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [
        "SUBGRP_STILLS_STEP"
      ],
      "negated": false
    },
    "SUBGRP_STILLS_STEP": {
      "group_id": "SUBGRP_STILLS_STEP",
      "name": "Still's Step Therapy",
      "description": "Steroid + DMARD OR Biologic Exception",
      "operator": "OR",
      "criteria": [
        "STEP_STILLS_THERAPY",
        "EXCEPTION_BIOLOGIC_BYPASS"
      ],
      "subgroups": [],
      "negated": false
    },
    "GRP_UVEITIS_INITIAL": {
      "group_id": "GRP_UVEITIS_INITIAL",
      "name": "Uveitis Initial",
      "description": "Initial criteria for Uveitis",
      "operator": "AND",
      "criteria": [
        "AGE_GE_6",
        "PRESCRIBER_OPHTH",
        "PREFERRED_PRODUCT_REQUIRED"
      ],
      "subgroups": [
        "SUBGRP_UVEITIS_STEP"
      ],
      "negated": false
    },
    "SUBGRP_UVEITIS_STEP": {
      "group_id": "SUBGRP_UVEITIS_STEP",
      "name": "Uveitis Step Therapy",
      "description": "Therapy Trial OR Biologic Exception",
      "operator": "OR",
      "criteria": [
        "STEP_UVEITIS_THERAPY",
        "EXCEPTION_BIOLOGIC_BYPASS"
      ],
      "subgroups": [],
      "negated": false
    },
    "SUBGRP_CD_SAFETY": {
      "group_id": "SUBGRP_CD_SAFETY",
      "name": "Pre-Biologic Safety Screening",
      "description": "Required safety screenings before initiating biologic therapy",
      "operator": "AND",
      "criteria": [
        "SAFETY_TB_NEGATIVE",
        "SAFETY_HEPATITIS_SCREENING"
      ],
      "subgroups": [],
      "negated": false
    }
  },
  "indications": [
    {
      "indication_id": "ANKYLOSING_SPONDYLITIS",
      "indication_name": "Ankylosing Spondylitis",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_AS_INITIAL",
      "continuation_criteria": "GRP_AS_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Ankylosing Spondylitis",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 6 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Ankylosing Spondylitis",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "M45.0",
          "display": "Ankylosing spondylitis of multiple sites in spine",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M45",
          "concept_text": "Ankylosing Spondylitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M45.9",
          "display": "Ankylosing spondylitis of unspecified sites in spine",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M45",
          "concept_text": "Ankylosing Spondylitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M45.1",
          "display": "Ankylosing spondylitis of occipito-atlanto-axial region",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "Ankylosing Spondylitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M45.2",
          "display": "Ankylosing spondylitis of cervical region",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "Ankylosing Spondylitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M45.3",
          "display": "Ankylosing spondylitis of cervicothoracic region",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "Ankylosing Spondylitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M45.4",
          "display": "Ankylosing spondylitis of thoracic region",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "Ankylosing Spondylitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M45.5",
          "display": "Ankylosing spondylitis of thoracolumbar region",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "Ankylosing Spondylitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M45.6",
          "display": "Ankylosing spondylitis of lumbar region",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "Ankylosing Spondylitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M45.7",
          "display": "Ankylosing spondylitis of lumbosacral region",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "Ankylosing Spondylitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M45.8",
          "display": "Ankylosing spondylitis of sacral and sacrococcygeal region",
          "source": "inferred",
          "consensus_status": "review_needed",
          "parent_code": null,
          "concept_text": "Ankylosing Spondylitis"
        }
      ]
    },
    {
      "indication_id": "CROHNS_DISEASE",
      "indication_name": "Crohn's Disease",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_CD_INITIAL",
      "continuation_criteria": "GRP_CD_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Crohn's Disease",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 8 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Crohn's Disease",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 6,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "K50.0",
          "display": "Crohn's disease of small intestine",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K50",
          "concept_text": "Crohn's Disease"
        },
        {
          "system": "ICD-10-CM",
          "code": "K50.1",
          "display": "Crohn's disease of large intestine",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K50",
          "concept_text": "Crohn's Disease"
        },
        {
          "system": "ICD-10-CM",
          "code": "K50.8",
          "display": "Other Crohn's disease",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K50",
          "concept_text": "Crohn's Disease"
        },
        {
          "system": "ICD-10-CM",
          "code": "K50.9",
          "display": "Crohn's disease, unspecified",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K50",
          "concept_text": "Crohn's Disease"
        }
      ]
    },
    {
      "indication_id": "PLAQUE_PSORIASIS",
      "indication_name": "Plaque Psoriasis",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_PSO_INITIAL",
      "continuation_criteria": "GRP_PSO_CONTINUATION",
      "initial_approval_duration_months": 3,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Plaque Psoriasis",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 8 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Plaque Psoriasis",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "L40.0",
          "display": "Psoriasis vulgaris",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Plaque Psoriasis"
        }
      ]
    },
    {
      "indication_id": "RHEUMATOID_ARTHRITIS",
      "indication_name": "Rheumatoid Arthritis",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_RA_INITIAL",
      "continuation_criteria": "GRP_RA_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Rheumatoid Arthritis",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 8 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Rheumatoid Arthritis",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "M05.7",
          "display": "Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M05",
          "concept_text": "Rheumatoid Arthritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M05.8",
          "display": "Other seropositive rheumatoid arthritis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M05",
          "concept_text": "Rheumatoid Arthritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M06.0",
          "display": "Seronegative rheumatoid arthritis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M06",
          "concept_text": "Rheumatoid Arthritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M06.8",
          "display": "Other specified rheumatoid arthritis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M06",
          "concept_text": "Rheumatoid Arthritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M06.9",
          "display": "Rheumatoid arthritis, unspecified",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M06",
          "concept_text": "Rheumatoid Arthritis"
        }
      ]
    },
    {
      "indication_id": "ULCERATIVE_COLITIS",
      "indication_name": "Ulcerative Colitis",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_UC_INITIAL",
      "continuation_criteria": "GRP_UC_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Ulcerative Colitis",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 8 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Ulcerative Colitis",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 6,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "K51.0",
          "display": "Ulcerative (chronic) pancolitis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K51",
          "concept_text": "Ulcerative Colitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "K51.2",
          "display": "Ulcerative (chronic) proctitis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K51",
          "concept_text": "Ulcerative Colitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "K51.3",
          "display": "Ulcerative (chronic) rectosigmoiditis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K51",
          "concept_text": "Ulcerative Colitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "K51.4",
          "display": "Inflammatory polyps of colon",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K51",
          "concept_text": "Ulcerative Colitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "K51.5",
          "display": "Left sided colitis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K51",
          "concept_text": "Ulcerative Colitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "K51.8",
          "display": "Other ulcerative colitis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K51",
          "concept_text": "Ulcerative Colitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "K51.9",
          "display": "Ulcerative colitis, unspecified",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "K51",
          "concept_text": "Ulcerative Colitis"
        }
      ]
    },
    {
      "indication_id": "BEHCETS_DISEASE",
      "indication_name": "Behcet's Disease",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_BEHCET_INITIAL",
      "continuation_criteria": "GRP_BEHCET_CONTINUATION",
      "initial_approval_duration_months": 3,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Behcet's Disease",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 6 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Behcet's Disease",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 6,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "M35.2",
          "display": "Behcet's disease",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Behcet's Disease"
        }
      ]
    },
    {
      "indication_id": "GVHD",
      "indication_name": "Graft-Versus-Host Disease",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_GVHD_INITIAL",
      "continuation_criteria": "GRP_GVHD_CONTINUATION",
      "initial_approval_duration_months": 1,
      "continuation_approval_duration_months": 3,
      "dosing_requirements": [
        {
          "indication": "Graft-Versus-Host Disease",
          "phase": "all",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once weekly",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": null
        }
      ],
      "min_age_years": 6,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "D89.81",
          "display": "Graft-versus-host disease",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Graft-Versus-Host Disease"
        }
      ]
    },
    {
      "indication_id": "HIDRADENITIS_SUPPURATIVA",
      "indication_name": "Hidradenitis Suppurativa",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_HS_INITIAL",
      "continuation_criteria": "GRP_HS_CONTINUATION",
      "initial_approval_duration_months": 3,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Hidradenitis Suppurativa",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 8 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Hidradenitis Suppurativa",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "L73.2",
          "display": "Hidradenitis suppurativa",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Hidradenitis Suppurativa"
        }
      ]
    },
    {
      "indication_id": "IMMUNOTHERAPY_TOXICITY",
      "indication_name": "Immunotherapy-Related Toxicities",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_IMMUNO_TOX_INITIAL",
      "continuation_criteria": "GRP_IMMUNO_TOX_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Immunotherapy-Related Toxicities",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 4 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Immunotherapy-Related Toxicities",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "T45.1X5",
          "display": "Adverse effect of antineoplastic and immunosuppressive drugs",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Immunotherapy-Related Toxicities"
        }
      ]
    },
    {
      "indication_id": "INDETERMINATE_COLITIS",
      "indication_name": "Indeterminate Colitis",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_INDETERMINATE_COLITIS_INITIAL",
      "continuation_criteria": "GRP_INDETERMINATE_COLITIS_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Indeterminate Colitis",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 8 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Indeterminate Colitis",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 6,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "K52.3",
          "display": "Indeterminate colitis",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Indeterminate Colitis"
        }
      ]
    },
    {
      "indication_id": "JIA",
      "indication_name": "Juvenile Idiopathic Arthritis",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_JIA_INITIAL",
      "continuation_criteria": "GRP_JIA_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Juvenile Idiopathic Arthritis",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 8 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Juvenile Idiopathic Arthritis",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 6,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "M08.0",
          "display": "Unspecified juvenile rheumatoid arthritis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M08",
          "concept_text": "Juvenile Idiopathic Arthritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M08.2",
          "display": "Juvenile rheumatoid arthritis with systemic onset",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M08",
          "concept_text": "Juvenile Idiopathic Arthritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M08.3",
          "display": "Juvenile rheumatoid polyarthritis (seronegative)",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M08",
          "concept_text": "Juvenile Idiopathic Arthritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M08.4",
          "display": "Pauciarticular juvenile rheumatoid arthritis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M08",
          "concept_text": "Juvenile Idiopathic Arthritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M08.8",
          "display": "Other juvenile arthritis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M08",
          "concept_text": "Juvenile Idiopathic Arthritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "M08.9",
          "display": "Juvenile arthritis, unspecified",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "M08",
          "concept_text": "Juvenile Idiopathic Arthritis"
        }
      ]
    },
    {
      "indication_id": "PYODERMA_GANGRENOSUM",
      "indication_name": "Pyoderma Gangrenosum",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_PYODERMA_INITIAL",
      "continuation_criteria": "GRP_PYODERMA_CONTINUATION",
      "initial_approval_duration_months": 4,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Pyoderma Gangrenosum",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 8 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Pyoderma Gangrenosum",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "L88",
          "display": "Pyoderma gangrenosum",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Pyoderma Gangrenosum"
        }
      ]
    },
    {
      "indication_id": "SARCOIDOSIS",
      "indication_name": "Sarcoidosis",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_SARCOIDOSIS_INITIAL",
      "continuation_criteria": "GRP_SARCOIDOSIS_CONTINUATION",
      "initial_approval_duration_months": 3,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Sarcoidosis",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 6 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Sarcoidosis",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "D86.0",
          "display": "Sarcoidosis of lung",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "D86",
          "concept_text": "Sarcoidosis"
        },
        {
          "system": "ICD-10-CM",
          "code": "D86.1",
          "display": "Sarcoidosis of lymph nodes",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "D86",
          "concept_text": "Sarcoidosis"
        },
        {
          "system": "ICD-10-CM",
          "code": "D86.2",
          "display": "Sarcoidosis of lung with sarcoidosis of lymph nodes",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "D86",
          "concept_text": "Sarcoidosis"
        },
        {
          "system": "ICD-10-CM",
          "code": "D86.3",
          "display": "Sarcoidosis of skin",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "D86",
          "concept_text": "Sarcoidosis"
        },
        {
          "system": "ICD-10-CM",
          "code": "D86.8",
          "display": "Sarcoidosis of other sites",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "D86",
          "concept_text": "Sarcoidosis"
        },
        {
          "system": "ICD-10-CM",
          "code": "D86.9",
          "display": "Sarcoidosis, unspecified",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "D86",
          "concept_text": "Sarcoidosis"
        }
      ]
    },
    {
      "indication_id": "SCLERITIS",
      "indication_name": "Scleritis or Sterile Corneal Ulceration",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_SCLERITIS_INITIAL",
      "continuation_criteria": "GRP_SCLERITIS_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Scleritis or Sterile Corneal Ulceration",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Baseline, then up to 3 additional doses (2, 6, 8 weeks)",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Scleritis or Sterile Corneal Ulceration",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "H15.0",
          "display": "Scleritis",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Scleritis"
        },
        {
          "system": "ICD-10-CM",
          "code": "H16.0",
          "display": "Corneal ulcer",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Sterile Corneal Ulceration"
        }
      ]
    },
    {
      "indication_id": "SPONDYLOARTHRITIS",
      "indication_name": "Spondyloarthritis, Other Subtypes",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_SPA_INITIAL",
      "continuation_criteria": "GRP_SPA_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Spondyloarthritis, Other Subtypes",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Baseline, then up to 3 additional doses (2, 6, 8 weeks)",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": "Initial dosing up to 10mg/kg"
        },
        {
          "indication": "Spondyloarthritis, Other Subtypes",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "M46.8",
          "display": "Other specified inflammatory spondylopathies",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Spondyloarthritis, Other Subtypes"
        }
      ]
    },
    {
      "indication_id": "STILLS_DISEASE",
      "indication_name": "Still's Disease",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_STILLS_INITIAL",
      "continuation_criteria": "GRP_STILLS_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Still's Disease",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 8 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Still's Disease",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 18,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "M06.1",
          "display": "Adult-onset Still's disease",
          "source": "inferred",
          "consensus_status": "confirmed",
          "parent_code": null,
          "concept_text": "Still's Disease"
        }
      ]
    },
    {
      "indication_id": "UVEITIS",
      "indication_name": "Uveitis",
      "indication_codes": [],
      "initial_approval_criteria": "GRP_UVEITIS_INITIAL",
      "continuation_criteria": "GRP_UVEITIS_CONTINUATION",
      "initial_approval_duration_months": 6,
      "continuation_approval_duration_months": 12,
      "dosing_requirements": [
        {
          "indication": "Uveitis",
          "phase": "induction",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "Weeks 0, 2, 6 then every 4 weeks",
          "max_dose": null,
          "max_dose_unit": null,
          "notes": null
        },
        {
          "indication": "Uveitis",
          "phase": "maintenance",
          "dose_value": null,
          "dose_unit": "mg/kg",
          "route": "IV",
          "frequency": "no more frequently than once every 4 weeks",
          "max_dose": 10.0,
          "max_dose_unit": "mg/kg",
          "notes": "Continuation max dose"
        }
      ],
      "min_age_years": 6,
      "max_age_years": null,
      "enriched_codes": [
        {
          "system": "ICD-10-CM",
          "code": "H20.0",
          "display": "Acute and subacute iridocyclitis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "H20",
          "concept_text": "Uveitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "H20.1",
          "display": "Chronic iridocyclitis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "H20",
          "concept_text": "Uveitis"
        },
        {
          "system": "ICD-10-CM",
          "code": "H20.9",
          "display": "Unspecified iridocyclitis",
          "source": "expanded",
          "consensus_status": "confirmed",
          "parent_code": "H20",
          "concept_text": "Uveitis"
        }
      ]
    }
  ],
  "exclusions": [
    {
      "exclusion_id": "EXCL_CONCURRENT_BIOLOGIC",
      "name": "Concurrent Use with Biologic/Targeted Synthetic",
      "description": "This medication should not be administered in combination with another biologic or with a targeted synthetic oral small molecule drug used for an inflammatory condition",
      "policy_text": "This medication should not be administered in combination with another biologic or with a targeted synthetic oral small molecule drug used for an inflammatory condition",
      "trigger_criteria": [],
      "trigger_group_id": null
    }
  ],
  "step_therapy_requirements": [
    {
      "requirement_id": "STEP_CD",
      "indication": "Crohn's Disease",
      "required_drugs": [],
      "required_drug_classes": [
        "corticosteroids",
        "conventional systemic therapy"
      ],
      "minimum_trials": 1,
      "minimum_duration_days": null,
      "failure_required": true,
      "intolerance_acceptable": true,
      "contraindication_acceptable": true,
      "documentation_requirements": []
    },
    {
      "requirement_id": "STEP_PSO",
      "indication": "Plaque Psoriasis",
      "required_drugs": [],
      "required_drug_classes": [
        "traditional systemic agent"
      ],
      "minimum_trials": 1,
      "minimum_duration_days": 90,
      "failure_required": true,
      "intolerance_acceptable": true,
      "contraindication_acceptable": true,
      "documentation_requirements": []
    },
    {
      "requirement_id": "STEP_RA",
      "indication": "Rheumatoid Arthritis",
      "required_drugs": [],
      "required_drug_classes": [
        "conventional synthetic DMARD"
      ],
      "minimum_trials": 1,
      "minimum_duration_days": 90,
      "failure_required": true,
      "intolerance_acceptable": true,
      "contraindication_acceptable": true,
      "documentation_requirements": []
    }
  ],
  "quantity_limits": [],
  "required_specialties": [
    "rheumatologist",
    "gastroenterologist",
    "dermatologist",
    "ophthalmologist",
    "oncologist",
    "hematologist",
    "cardiologist",
    "nephrologist",
    "pulmonologist",
    "neurologist"
  ],
  "consultation_allowed": true,
  "safety_screenings": [
    {
      "screening_id": "TB_SCREENING",
      "screening_name": "Tuberculosis Screening",
      "required_tests": [
        "QuantiFERON-TB Gold Plus or tuberculin skin test"
      ],
      "required_result": "negative",
      "timing": "Prior to initiating therapy",
      "applies_to": "all indications"
    },
    {
      "screening_id": "HEPATITIS_SCREENING",
      "screening_name": "Hepatitis B and C Screening",
      "required_tests": [
        "HBsAg",
        "anti-HBc",
        "anti-HBs",
        "HCV antibody"
      ],
      "required_result": "completed",
      "timing": "Prior to initiating therapy",
      "applies_to": "all indications"
    }
  ],
  "policy_type": "medical_benefit_pa",
  "version": "v2",
  "extraction_timestamp": "2026-02-26T02:01:18.299482+00:00",
  "extraction_model": "gemini",
  "source_document_hash": "bad0805a670f166ac00bb8d624abb468bcb029589a4e61770e2a46c0e73bc354",
  "extraction_pipeline_version": "2.0",
  "validation_model": "claude",
  "extraction_quality": "needs_review",
  "provenances": {
    "AGE_GE_18": {
      "criterion_id": "AGE_GE_18",
      "source_page": 5,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient is >= 18 years of age",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "AGE_GE_6": {
      "criterion_id": "AGE_GE_6",
      "source_page": 6,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient is >= 6 years of age",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "PRESCRIBER_RHEUM": {
      "criterion_id": "PRESCRIBER_RHEUM",
      "source_page": 5,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "The medication is prescribed by or in consultation with a rheumatologist",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "PRESCRIBER_GI": {
      "criterion_id": "PRESCRIBER_GI",
      "source_page": 6,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "The medication is prescribed by or in consultation with a gastroenterologist",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "PRESCRIBER_DERM": {
      "criterion_id": "PRESCRIBER_DERM",
      "source_page": 7,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "The medication is prescribed by or in consultation with a dermatologist",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "PRESCRIBER_RHEUM_DERM": {
      "criterion_id": "PRESCRIBER_RHEUM_DERM",
      "source_page": 8,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "The medication is if prescribed by or in consultation with a rheumatologist or a dermatologist",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "PRESCRIBER_OPHTH": {
      "criterion_id": "PRESCRIBER_OPHTH",
      "source_page": 15,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "The medication is prescribed by or in consultation with an ophthalmologist",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_CD_STEROIDS": {
      "criterion_id": "STEP_CD_STEROIDS",
      "source_page": 6,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient has tried or is currently taking corticosteroids, or corticosteroids are contraindicated in this patient",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_CD_CONVENTIONAL": {
      "criterion_id": "STEP_CD_CONVENTIONAL",
      "source_page": 6,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient has tried one other conventional systemic therapy for Crohn's disease",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "EXCEPTION_BIOLOGIC_BYPASS": {
      "criterion_id": "EXCEPTION_BIOLOGIC_BYPASS",
      "source_page": 6,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "An exception to the requirement... can be made if the patient has already tried at least one biologic other than the requested medication.",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CLINICAL_CD_FISTULAS": {
      "criterion_id": "CLINICAL_CD_FISTULAS",
      "source_page": 6,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient has enterocutaneous (perianal or abdominal) or rectovaginal fistulas",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CLINICAL_CD_RESECTION": {
      "criterion_id": "CLINICAL_CD_RESECTION",
      "source_page": 6,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient had ileocolonic resection",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_PSO_SYSTEMIC": {
      "criterion_id": "STEP_PSO_SYSTEMIC",
      "source_page": 7,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient has tried at least one traditional systemic agent for psoriasis for at least 3 months",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_PSO_PUVA": {
      "criterion_id": "STEP_PSO_PUVA",
      "source_page": 7,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "A 3-month trial of psoralen plus ultraviolet A light (PUVA) also counts.",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "EXCEPTION_PSO_PRIOR_BIOLOGIC_OR_ORAL": {
      "criterion_id": "EXCEPTION_PSO_PRIOR_BIOLOGIC_OR_ORAL",
      "source_page": 7,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "An exception... can be made if the patient already had a 3-month trial or previous intolerance to at least one biologic... Otezla/Otezla XR... or Sotyktu",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CONTRAINDICATION_MTX": {
      "criterion_id": "CONTRAINDICATION_MTX",
      "source_page": 7,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "According to the prescriber, the patient has a contraindication to methotrexate",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_RA_DMARD": {
      "criterion_id": "STEP_RA_DMARD",
      "source_page": 8,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient has tried ONE conventional synthetic disease-modifying antirheumatic drug (DMARD) for at least 3 months",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_BEHCET_CONVENTIONAL": {
      "criterion_id": "STEP_BEHCET_CONVENTIONAL",
      "source_page": 10,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried at least ONE conventional therapy",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CLINICAL_BEHCET_OPHTHALMIC": {
      "criterion_id": "CLINICAL_BEHCET_OPHTHALMIC",
      "source_page": 10,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has ophthalmic manifestations of Behcet's disease",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "DIAG_ACUTE_GVHD": {
      "criterion_id": "DIAG_ACUTE_GVHD",
      "source_page": 10,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has acute graft-versus-host disease",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_GVHD_SYSTEMIC": {
      "criterion_id": "STEP_GVHD_SYSTEMIC",
      "source_page": 10,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried at least one systemic medication for graft-versus-host disease",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_HS_THERAPY": {
      "criterion_id": "STEP_HS_THERAPY",
      "source_page": 11,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried one other therapy",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CLINICAL_IMMUNO_TOX": {
      "criterion_id": "CLINICAL_IMMUNO_TOX",
      "source_page": 12,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "patient developed an immunotherapy-related toxicity other than hepatitis",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_IMMUNO_TOX_STEROID": {
      "criterion_id": "STEP_IMMUNO_TOX_STEROID",
      "source_page": 12,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried one systemic corticosteroid",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_INDETERMINATE_COLITIS": {
      "criterion_id": "STEP_INDETERMINATE_COLITIS",
      "source_page": 12,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried one systemic corticosteroid; AND Patient has tried mesalamine; AND Patient has tried either azathioprine or 6-mercaptopurine",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_JIA_SYSTEMIC": {
      "criterion_id": "STEP_JIA_SYSTEMIC",
      "source_page": 13,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried one other systemic medication for this condition",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CLINICAL_JIA_AGGRESSIVE": {
      "criterion_id": "CLINICAL_JIA_AGGRESSIVE",
      "source_page": 13,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has aggressive disease, as determined by the prescriber",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_PYODERMA_STEROID": {
      "criterion_id": "STEP_PYODERMA_STEROID",
      "source_page": 14,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried one systemic corticosteroid",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_PYODERMA_IMMUNO": {
      "criterion_id": "STEP_PYODERMA_IMMUNO",
      "source_page": 14,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried one other immunosuppressant for at least 2 months",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_SARCOIDOSIS": {
      "criterion_id": "STEP_SARCOIDOSIS",
      "source_page": 15,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried at least one corticosteroid; AND Patient has tried at least one immunosuppressive medication",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_SCLERITIS": {
      "criterion_id": "STEP_SCLERITIS",
      "source_page": 15,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried one other therapy for this condition",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_SPA_PERIPHERAL": {
      "criterion_id": "STEP_SPA_PERIPHERAL",
      "source_page": 16,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has arthritis primarily in the knees... AND has tried at least ONE conventional synthetic disease-modifying antirheumatic drug",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CLINICAL_SPA_AXIAL": {
      "criterion_id": "CLINICAL_SPA_AXIAL",
      "source_page": 16,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has axial spondyloarthritis with objective signs of inflammation",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_STILLS_THERAPY": {
      "criterion_id": "STEP_STILLS_THERAPY",
      "source_page": 17,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried one corticosteroid; AND Patient has tried one conventional synthetic disease-modifying antirheumatic drug (DMARD) given for at least 2 months",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "STEP_UVEITIS_THERAPY": {
      "criterion_id": "STEP_UVEITIS_THERAPY",
      "source_page": 18,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has tried one of the following therapies: periocular, intraocular, or systemic corticosteroids, or immunosuppressives",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CONTINUATION_ESTABLISHED_6MO": {
      "criterion_id": "CONTINUATION_ESTABLISHED_6MO",
      "source_page": 5,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient has been established on therapy for at least 6 months",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CONTINUATION_ESTABLISHED_3MO": {
      "criterion_id": "CONTINUATION_ESTABLISHED_3MO",
      "source_page": 7,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient has been established on therapy for at least 3 months",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CONTINUATION_ESTABLISHED_1MO": {
      "criterion_id": "CONTINUATION_ESTABLISHED_1MO",
      "source_page": 11,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has been established on an infliximab product for at least 1 month",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "CONTINUATION_ESTABLISHED_4MO": {
      "criterion_id": "CONTINUATION_ESTABLISHED_4MO",
      "source_page": 14,
      "source_section": "Other Uses with Supportive Evidence",
      "source_text_excerpt": "Patient has been established on therapy for at least 4 months",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "RESPONSE_OBJECTIVE_AS": {
      "criterion_id": "RESPONSE_OBJECTIVE_AS",
      "source_page": 6,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "When assessed by at least one objective measure, patient experienced a beneficial clinical response",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "RESPONSE_SUBJECTIVE_AS": {
      "criterion_id": "RESPONSE_SUBJECTIVE_AS",
      "source_page": 6,
      "source_section": "FDA-Approved Indications",
      "source_text_excerpt": "Patient experienced an improvement in at least one symptom",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "PREFERRED_PRODUCT_REQUIRED": {
      "criterion_id": "PREFERRED_PRODUCT_REQUIRED",
      "source_page": 5,
      "source_section": "Policy Statement",
      "source_text_excerpt": "This product also requires the use of preferred products before approval of a requested non-preferred infliximab intravenous product.",
      "extraction_confidence": "high",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "GRP_RA_CONTINUATION": {
      "criterion_id": "GRP_RA_CONTINUATION",
      "source_page": null,
      "source_section": null,
      "source_text_excerpt": "Patient is Currently Receiving an Infliximab Product. Approve for 1 year if the patient meets BOTH of the following (i and ii): i. Patient has been established on therapy for at least 6 months; AND ii. Patient meets at least ONE of the following (a or b): a) Patient experienced a beneficial clinical response when assessed by at least one objective measure; OR b) Patient experienced an improvement in at least one symptom",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "GRP_UC_CONTINUATION": {
      "criterion_id": "GRP_UC_CONTINUATION",
      "source_page": null,
      "source_section": null,
      "source_text_excerpt": "Patient is Currently Receiving an Infliximab Product. Approve for 1 year if the patient meets BOTH of the following (i and ii): i. Patient has been established on therapy for at least 6 months; AND ii. Patient meets at least ONE of the following (a or b): a) When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline; OR b) Compared with baseline, patient experienced an improvement in at least one symptom",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "GRP_BEHCET_CONTINUATION": {
      "criterion_id": "GRP_BEHCET_CONTINUATION",
      "source_page": null,
      "source_section": null,
      "source_text_excerpt": "Patient is Currently Receiving an Infliximab Product. Approve for 1 year if the patient meets ALL of the following (i, ii, and iii): i. Patient has been established on therapy for at least 3 months; AND ii. When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline; AND iii. Compared with baseline, patient experienced an improvement in at least one symptom",
      "extraction_confidence": "low",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    },
    "PRESCRIBER_NEURO": {
      "criterion_id": "PRESCRIBER_NEURO",
      "source_page": null,
      "source_section": null,
      "source_text_excerpt": "The medication is prescribed by or in consultation with a rheumatologist, dermatologist, ophthalmologist, gastroenterologist, or neurologist",
      "extraction_confidence": "medium",
      "validation_action": "corrected",
      "validation_reasoning": null,
      "code_validation_results": {}
    }
  },
  "codification_metadata": {
    "codification_timestamp": "2026-02-26T02:07:14.295457+00:00",
    "codification_model_a": "gemini",
    "codification_model_b": "claude",
    "total_codes_proposed": 162,
    "confirmed_codes": 150,
    "review_needed_codes": 11,
    "rejected_codes": 1,
    "criteria_codified": 27,
    "indications_codified": 17
  }
}